# EksoNR at United States: deployment

Canonical ID: `cbb9eca5-f3b7-4400-a536-a8b6c8b973f6`

EksoNR is FDA-cleared for stroke, SCI, acquired brain injury, and multiple sclerosis (first exoskeleton cleared for MS, June 2022). Deployed in 375+ rehabilitation centers worldwide with 200+ published articles. Q1 2026 revenue: Americas $1.55M, EMEA $0.55M, APAC $0.04M. Company disclosed going-concern warning in Q1 2026 10-Q. Pending Business Combination with Applied Digital Cloud (ChronoScale). Go-to-market partners include National Seating & Mobility, Bionic Prosthetics & Orthotics Group, and Ottobock Patient Care.

## Key facts

- **FDA clearances:** Stroke (2016), SCI T4-L5 and C7-T3 ASIA D, ABI (2020), MS (June 2022, K220988) — first exoskeleton cleared for MS rehab
- **Clinical scale:** 375+ rehabilitation centers worldwide; 200+ published articles; 2,000+ patients across 185+ clinical studies
- **Americas revenue Q1 2026:** $1.55M (US $1.53M)
- **Going concern:** Q1 2026 10-Q discloses substantial doubt; cash funds operations into early Q3 2026; Business Combination with Applied Digital Cloud pending
- **Go-to-market partners:** National Seating & Mobility, Bionic Prosthetics & Orthotics Group, Ottobock Patient Care

**Trust tier:** Catalog entry · 2 sources · not yet field-verified

_Last updated: 2026-06-07_

- **Slug:** ekso-nr-united-states
- **Status:** active
- **Model:** [EksoNR](/models/ekso-nr.md) (id: `a4a2491a-bfdd-4ba3-b370-771d234bc136`)
- **Company:** [Ekso Bionics](/companies/ekso-bionics.md) (id: `c36c0cb6-a327-458b-94ec-288386588250`)
- **Location:** [United States](/locations/united-states.md) (id: `aa8b9c05-c836-4021-801f-59801970401e`)

## Verification log (0, append-only)

_No verifications recorded._

## Sources (2)

1. https://eksobionics.com/en/eksonr/
2. https://ir.chronoscale.com/press-releases/detail/729/ekso-bionics-receives-fda-clearance-to-market-its-eksonr

## Common questions

### What is the EksoNR deployment at United States?

EksoNR, built by Ekso Bionics, is recorded as a deployment at United States on the DEPLOY registry. Ekso Bionics operates the deployment directly.

### Who operates EksoNR at United States?

Ekso Bionics, the manufacturer of EksoNR, operates this deployment directly. This is a maker-deploys-its-own-product arrangement rather than a customer pilot.

### Is the EksoNR deployment at United States still active?

As of the most recent verification on the DEPLOY registry, this deployment is currently operating.

### Have there been incidents at the EksoNR deployment at United States?

No active incidents affecting this deployment are recorded on the DEPLOY registry. Absence of recorded incidents is not a guarantee no incident occurred; DEPLOY records only sourced incidents and suppresses retracted ones.


_API: GET /v1/robots/cbb9eca5-f3b7-4400-a536-a8b6c8b973f6 · feeds: GET /v1/feeds?deploymentId=cbb9eca5-f3b7-4400-a536-a8b6c8b973f6 · canonical URL: /deployments/ekso-nr-united-states_